Responses
Clinical/translational cancer immunotherapy
Original research
Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.
